HIV Drug Study Highlights Difference In Kidney, Liver Risks Between Older and Newer Gilead Drugs
A new study and HIV drug recommendations highlights the safety differences between newer and older Gilead HIV medications.…
«
»
A new study and HIV drug recommendations highlights the safety differences between newer and older Gilead HIV medications.…
Gilead faces a class action lawsuit over claims it bribed a generic competitor into not releasing its own version of the Truvada HIV drug.…
A new HIV drug lawsuit against Gilead details kidney and bone injuries suffered by 12 people who say the company withheld safer formulations of its drugs to increase profit margins.…
A lawsuit filed by a group of plaintiffs accuses Gilead of failing to provide adequate warnings on its HIV drugs, and hiding safer formulations away until it could best profit from them.…
Gilead faces a joint lawsuit from 20 plaintiffs who say it promoted HIV drugs which increased the risk of kidney and bone damage.…
An HIV drug lawsuit filed by more than 70 people accuses the drug manufacturer Gilead of purposefully exposing HIV patients to unnecessarily toxic drugs to maximize profits.…
A new ISMP report warns of certain medication errors which appear to be linked to the rush to address the COVID-19 pandemic.…
Gilead has filed a lawsuit against the U.S. government, claiming it breached multiple contractual agreements by pursuing patents on Truvada during the company’s collaboration with the CDC.
…
Dozens of plaintiffs have filed a joint lawsuit against Gilead in federal court, claiming it failed to adequately warn about the kidney and bone risks linked to its HIV drugs, and withheld safer formulations in order to maximize profits.…
A federal judge will allow a class action lawsuit against Gilead and other drug manufacturers to proceed, which alleges they violated antitrust laws to prevent generic versions of the company’s HIV drugs to hit the market.…